Drug Shortage Report for PREVYMIS
Report ID | 92759 |
Drug Identification Number | 02469367 |
Brand name | PREVYMIS |
Common or Proper name | Letermovir for injection |
Company Name | MERCK CANADA INC |
Market Status | MARKETED |
Active Ingredient(s) | LETERMOVIR |
Strength(s) | 20MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS |
Packaging size | 1 x Vial |
ATC code | J05AX |
ATC description | DIRECT ACTING ANTIVIRALS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2020-03-02 |
Actual start date | 2020-03-02 |
Estimated end date | 2020-06-05 |
Actual end date | 2020-06-04 |
Shortage status | Resolved |
Updated date | 2020-06-05 |
Company comments | The tablets presentations are available |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 16750 ROUTE TRANSCANADIENNE KIRKLAND, QUEBEC CANADA H9H 4M7 |
Company contact information | 1-800-567-2594 medinfocanada@merck.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v11 | 2020-06-05 | English | Compare |
v10 | 2020-06-04 | French | Compare |
v9 | 2020-06-04 | English | Compare |
v8 | 2020-04-07 | English | Compare |
v7 | 2020-03-03 | English | Compare |
v6 | 2020-03-02 | English | Compare |
v5 | 2020-02-24 | English | Compare |
v4 | 2020-02-24 | English | Compare |
v3 | 2019-09-19 | English | Compare |
v2 | 2019-08-30 | French | Compare |
v1 | 2019-08-30 | English | Compare |
Showing 1 to 11 of 11